Daily non-political popular news in brief.
Combination HDL/LDL therapy has no effect on plaque build-up
03-26-2007 · EurekAlert!Two RADIANCE studies presented today at the American College of Cardiology's 56th Annual Scientific Session assessed the effects of adding torcetrapib to atorvastatin among patients to improve their cholesterol levels. Although the ILLUMINATE study and other trials involving torcetrapib were recently stopped because of safety concerns, the effect of the drug on carotid intima-media thickness (CIMT) may provide useful information on whether it slows the progression of atherosclerosis.
Read more »
Keywords: combination, hdl, ldl, therapy, effect, plaque, build-up, build
« Previous | Next »
Similar news on "Combination HDL/LDL therapy has no effect on plaque build-up":
- Drug that mimics 'good' cholesterol has mixed effect on coronary atherosclerosis
03-26-2007 · EurekAlert!
The results of a study presented today at the American College of Cardiology’s 56th Annual Scientific Session showed that CSL-111, a drug that mimics HDL, did not significantly reduce plaque in coronary arteries in patients with a recent episode of ACS. However, patients taking the drug showed improvement in two indexes that assess changes in the blood vessels.
Similar news · Read more »
- Gene Transfer Using Mutant Form Of Good Cholesterol Cuts Vascular Plaque And Inflammation
09-30-2006 · ScienceDaily
Transfer of a gene that produces a mutant form of good cholesterol provides significantly better anti-plaque and anti-inflammation benefits than therapy using the "normal" HDL gene, according to a mouse study conducted by cardiology researchers at Cedars-Sinai Medical Center and reported in the Oct. 3 issue of the Journal of the American College of Cardiology.
Similar news · Read more »
- Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
03-27-2007 · EurekAlert!
Heart attacks are caused by a build-up and instability of plaque in the coronary arteries, which is often a result of chronic inflammation of the blood vessel walls. A study presented today at the American College of Cardiology's 56th Annual Scientific Session assessed whether adding a novel agent with antioxidant and anti-inflammatory properties to optimal medical therapy would reduce coronary events and death among patients with heart disease.
Similar news · Read more »
- Statin therapy associated with regression of coronary atherosclerosis with key lipid level changes
02-06-2007 · EurekAlert!
An analysis of data from four clinical trials suggests that statin therapy is associated with regression of coronary atherosclerosis when low-density lipoprotein cholesterol (LDL-C or "bad" cholesterol) is substantially reduced and high-density lipoprotein cholesterol (HDL-C or "good" cholesterol) is increased, but it remains to be determined whether this degree of atherosclerosis regression will translate to meaningful reductions in cardiovascular events, according to a study published in the Feb. 7 issue of JAMA.
Similar news · Read more »
- Combination therapy improves survival for certain prostate cancer patients
01-22-2008 · EurekAlert!
Men with localized prostate cancer who were treated with male hormone suppression therapy and radiation treatment had longer survival, but those with moderate to high levels of other illnesses did not experience this effect, according to a study in the Jan. 23 issue of JAMA.
Similar news · Read more »
- Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
01-09-2007 · EurekAlert!
Using a new and dramatically effective treatment approach, scientists at the Scripps Research Institute have for the first time achieved complete inhibition of new blood vessel growth in animal models of a highly vascular brain tumor and of neovascular eye diseases with little or no effect on normal tissue vasculature.
Similar news · Read more »
- Order of chemotherapy, radiation has no effect on breast cancer survival
10-30-2006 · EurekAlert!
For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.
Similar news · Read more »
- Experimental MS drug shows promise, offers new window on disease
02-13-2008 · EurekAlert!
A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
Similar news · Read more »
- More on mate tea: lower cholesterol and an international agreement
10-23-2007 · EurekAlert!
When a study in her lab showed that mate tea drinkers saw a significant increase in the activity of an enzyme that raises HDL cholesterol while lowering LDL cholesterol, University of Illinois scientist Elvira de Mejia headed for Argentina where mate tea has been used medicinally for centuries. She returned with a five-year agreement with administrators of La Universidad Nacional de Misiones to cooperate in the study of 84 genotypes of mate tea.
Similar news · Read more »
- Survey indicates people with chronic moderate to severe plaque psoriasis may be undertreated
02-02-2007 · EurekAlert!
The National Psoriasis Foundation and Amgen today released data, which show that nearly 40 percent of patients with chronic moderate to severe psoriasis are not currently receiving any treatment. Further, more than half of moderate to severe patients on treatment are not being treated in accordance with AAD guidelines, which state that patients diagnosed with chronic moderate to severe plaque psoriasis are candidates for phototherapy or systemic therapy, including biologic agents.
Similar news · Read more »
